Beaufour IPSEN China Your background before joining Beaufour Ipsen is quite unique among country managers of pharmaceutical companies: working many years in academia and focused very much on Asian studies. What brought you to the pharmaceutical industry? I have a very long personal history with China, starting back in my student days. I…
Merck Serono China As growth has stalled in Europe, the US and Japan, many multinational companies are looking at China as part of a hedging strategy and a key growth driver of the future. You must be feeling a lot of pressure from company headquarters as well as the natural pressures of working…
Alliance of Bio-Box Outsourcing China Could you please give a brief introduction to the ABO and its history? ABO was established in 2005. The CRO business emerged in 2000 in China, and provided services for medicine factories; however, these CRO companies were small as individuals. As a result, they were gathered together and ABO was…
Biogen Idec - China You have been here in China for about a year. What were your assumptions about China before you arrived and were things more or less what you thought they would be or were you surprised about the reality on the ground? We conducted extensive research and scouting before setting up…
China Pharmaceutical Enterprises Association First, let me briefly introduce myself. I used to work in Fuxin, a small city in the industrially advanced province of Liaoning which is equivalent to a state in the US. I worked in a company’s pharmaceutical factory for twenty years holding various positions such as technology director, factory head,…
Novo Nordisk China We found a Capital Markets Day presentation from Novo Nordisk that talked about the “rule of halves” – that of all people with diabetes, 50% of diagnosed, and of those 50% have access to care, and of those 50% get decent care, and finally 50% of those reach their targets.…
China In the last decade the medical device sector has undergone a lot of change; China has become a net importer to a net exporter of these devices. What is your outlook as to how this happened so quickly and what the key factors that revolutionized the industry? During the first…
Array Liam Condon, Managing Director of Bayer Healthcare China discusses the  government’s recent announcements regarding its much-anticipated healthcare reform plan, the future benefits of investing in rural healthcare, and the company’s main ambitions in China over the next five years. It has been a rollercoaster four years…
HUYA Bioscience International - China Your business is very much relationship based here in China. You’ve now established a number of relationships with institutes, universities and companies, but I can imagine that breaking into this market and building those relationships was a challenge. How did you grow this business in the early days? The early…
See our Cookie Privacy Policy Here